NASHVILLE, Tennessee—National Seating & Mobility (NSM), a provider of complex rehabilitation technology (CRT), mobility and accessibility solutions, has announced a commercial partnership with Wandercraft, a global robotics company specializing in self-balancing, AI-enabled mobility systems.
The two companies are partnering in preparation for future access to Eve, Wandercraft’s self-balancing personal exoskeleton designed for home use. Eve is currently under Food & Drug Administration regulatory review, with an anticipated launch this summer pending clearance.
Following FDA clearance, NSM will become Wandercraft’s exclusive complex rehab technology distribution partner for Eve, using its national network to support evaluation, education, access and delivery to eligible individuals with spinal cord injuries and other severe mobility impairments. The companies said the agreement is designed to help ensure that clinicians, assistive technology professionals, payers and clients are prepared to understand Eve’s role in extending upright mobility from rehabilitation settings into the home.
Eve is initially intended for individuals with spinal cord injuries. Built on the AI-enabled robotics platform, Eve adapts to users’ movements in real time. Eve is designed to support hands-free standing and walking with the assistance of a trained companion.
“Robotics and physical AI are redefining what’s possible for people with complex mobility needs,” said Crispin Teufel, CEO of NSM. “Close collaboration with our clinical partners and clients uniquely positions us to support the adoption of this innovative technology. Through this partnership with Wandercraft, we can broaden access in both rehabilitation and home environments.”
“Our mission is to help as many people as possible achieve their goals of standing, walking and living life upright and hands-free,” said Matthieu Masselin, co-founder and CEO of Wandercraft. “For many living with severe mobility impairments, standing and walking are not abstract aspirations—they are deeply meaningful experiences that shape daily life at home, with family, at work and in the community. Bringing those experiences to more people requires a partner with strong clinical relationships and expertise in complex mobility. NSM’s national presence, CRT leadership and deep connections with clinicians and clients make it the ideal partner as we prepare for Eve’s introduction and broaden access from rehabilitation to home.”
Wandercraft and NSM said they will also work with healthcare professionals, insurers, policymakers and other stakeholders to build understanding of the clinical, human and economic value of personal exoskeleton technology.